AONC - American Oncology Network Company Long-Term Liabilities

Public company logo of aoncology.com (AONC)

American Oncology Network (AONC) maintains high margins due to its regional influence and favorable terms with insurance organizations. The business generates revenue through the operation of its oncology center network, offering comprehensive therapy and medications via collaboration with physicians. This financial price chart featuring the 0.00 indicator confirms the stability of cash flows, which enable the prompt funding of current needs and clinic expansion.

American Oncology Network (AONC) Company Long-Term Debt: for the period 02/21/2024 - 08/04/2024
Brand item of AON

Long-term debt reflects the obligations of American Oncology Network (AONC) with maturities exceeding one year, determining its financial stability. This metric aggregates all long-term loans and bonds, demonstrating the business's reliance on leveraged capital. By analyzing the corporation's history of long-term loans and borrowings, an investor assesses the risk of default or excessive management conservatism. Growth in this indicator for American Oncology Network (AONC) is often linked to the expansion of its network of independent oncology practices. The centralization of laboratories and pharmacies requires capital expenditures, which is directly reflected in the debt dynamics.

Competitors of American Oncology Network (AONC)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|AURA: Company Long-Term Liabilities|CADL - Company Long-Term Debts|Accuray (ARAY) - Company Long-Term Debt|SELLAS Life Sciences Group - Company Long-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Long-Term Debts|Long-Term Debt Citius Oncology Inc CTOR|Company Long-Term Debts HURA|Company Long-Term Debts protaratx.com (TARA)|Company Long-Term Debt Fate Therapeutics FATE|WHWK - Company Long-Term Liabilities|TScan - Company Long-Term Debts|Long-Term Debt Champions Oncology|xbiotech.com (XBIT) - Company Long-Term Debt|CEL-SCI - Company Long-Term Loans and Borrowings|OSTX (OS Therapies) - Company Long-Term Debts|Radiopharm Theranostics Ltd (RADX) - Long-Term Debt Volume|Company Long-Term Debts ARTV|Company Long-Term Liabilities adlainortye.com ANL|Company Long-Term Debts VERU (Veru Inc.)|Company Long-Term Debts tempesttx.com TPST|XLO - Company Long-Term Debt|RENB (Renovaro Inc.) - Company Long-Term Indebtedness|MURA (muraloncology.com) - Company Long-Term Liabilities|Kairos Pharma - Company Long-Term Loans and Borrowings|Company Long-Term Debt OnKure Therapeutics, Inc.|Long-Term Debt CytoMed GDTC|Company Long-Term Debt Curis, Inc. (CRIS)|apollomicsinc.com - Company Long-Term Indebtedness|Company Long-Term Debts THAR (Tharimmune Corp)|ADVB - Company Long-Term Liabilities|GNPX - Company Long-Term Debt|Long-Term Debt Calidi Biotherapeutics|Sunshine Biopharma (SBFM) - Company Long-Term Debt|XBIO (Xenetic Biosciences, Inc.) - Company Long-Term Debt|Company Long-Term Debt Salarius|Long-Term Debt Kitov Pharma PPBT|Company Long-Term Debts BGNE|checkpointtx.com (CKPT) - Long-Term Indebtedness|Elevation Oncology, Inc. - Company Long-Term Liabilities|iCAD Inc. (ICAD) - Long-Term Debt|IKNA: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings NTBL (Notable Labs Corp)|viracta.com (VIRX) - Company Long-Term Debt|Company Long-Term Indebtedness MOR|NAYA (NAYA Biosciences Inc.) - Company Long-Term Debts|Long-Term Debt Ascentage Pharma Group International AAPGV